Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints CEO of PrimeVigilance

Dr Jan Petracek to drive pharmacoviglance business

Jan_Petracek_ErgomedErgomed has appointed Dr Jan Petracek the new CEO of its pharmacoviglance business PrimeVigilance.

Dr Petracek was previously CEO of European PharmInvent Services, which Ergomed acquired in 2016 and subsequently integrated into PrimeVigilance, and prior to that he served at the likes of MediWound and Vertext Pharmaceuticals.

Dr Miroslav Reljanovic, CEO of Ergomed, said: “We are fortunate to have in the wings a replacement CEO of the calibre of Dr Jan Petracek.

“As founder of PharmInvent and former regulator at EMA, his unique combination of entrepreneurship and specialist pharmacoviglance expertise will serve to drive forward our pharmacoviglance businesses.”

Petracek will succeed Neil Clark who will become CEO of Destiny Pharma and will remain on Ergomed’s board of PrimeVigilance as a non-executive director and consultant during a transition period.

26th April 2017

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Stick or Twist? Healthcare brands in a (post) COVID-19 world
...